15 Biggest Mid-Day Gainers For Monday - Ocean Power Techs (AMEX:OPTT)

Biomerica, Inc. BMRA shares surged 27.7 percent to $2.68.
Neuroderm Ltd NDRM shares jumped 26.7 percent to $19.70 as the company disclosed that it will replace two Phase 3 clinical trials with small pharmacokinetic trials following the FDA meeting on ND0612 regulatory development.
Stone Energy Corporation SGY gained 23.7 percent to $8.55. Stone Energy shares have dipped 85.98 percent over the past 52 weeks, while the S&P 500 index has increased 5.53 percent in the same period.
Bonanza Creek Energy Inc BCEI shares climbed 20 percent to $1.38.
Tidewater Inc. TDW rose 19.2 percent to $3.13. Tidewater shares have declined 65.12 percent over the past 52 weeks, while the S&P 500 index has increased 5.53 percent in the same period.
Quantenna Communications Inc QTNA shares rose 15 percent to $19.35. Needham upgraded Quantenna Communications from Buy to Strong Buy.
Selecta Biosciences Inc SELB gained 13.3 percent to $22.21. Spark Therapeutics Inc ONCE disclosed that it has entered into a licensing agreement with Selecta Biosciences.
FairPoint Communications Inc FRP shares climbed 11.9 percent to $19.02 after Consolidated Communications Holdings Inc CNSL announced plans to acquire FairPoint Communications for $1.5 billion in an all-stock merger.
Ocean Power Technologies Inc OPTT shares climbed 9.6 percent to $3.54. Ocean Power Technologies and Sonalysts reported a joint marketing agreement.
HollyFrontier Corp HFC rose 6.6 percent to $31.15. Credit Suisse upgraded HollyFrontier from Neutral to Outperform.
New Oriental Education & Tech Grp (ADR) EDU shares gained 5.9 percent to $44.48 after the company responded to recent media report. The company said it does not condone kinds of behavior described in the reports.
Sanderson Farms, Inc. SAFM rose 4.6 percent to $85.73. DA Davidson upgraded Sanderson Farms from Neutral to Buy
Conn's Inc CONN shares gained 4.6 percent to $11.30. Conn's is expected to report Q3 results on December 6, 2016.
Eleven Biotherapeutics Inc EBIO shares rose 4.1 percent to $2.49 after climbing 13.81 percent on Friday.
Bioline RX Ltd BLRX shares rose 3.4 percent to $1.01 after the company disclosed that it has presented positive Phase 2a AML study and mechanism-of-action data for BL-8040 oncology platform at the ASH 2016.

Market News and Data brought to you by Benzinga APIs